Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 15.94B 2.36B 2.07B 1.92B 1.77B 3.31B 227B 3.38B 22.92B 8.94B 111B 8.84B 8.65B 386B P/E 2026 *
30.6x
P/E 2027 * -154x
Enterprise Value 15.94B 2.36B 2.07B 1.92B 1.77B 3.31B 227B 3.38B 22.92B 8.94B 111B 8.84B 8.65B 386B EV / Sales 2026 *
14.8x
EV / Sales 2027 * 12.7x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-1.31%
1 week-13.17%
Current month-4.69%
1 month+7.28%
3 months-0.39%
6 months+0.62%
Current year+5.90%
1 week 33.5
Extreme 33.5
41.82
1 month 31.99
Extreme 31.99
44.8
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
81.48
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.5778
81.48
Manager TitleAgeSince
Chief Executive Officer 52 11/11/2015
Director of Finance/CFO 60 11/11/2015
Investor Relations Contact 38 31/12/2020
Director TitleAgeSince
Chairman 52 11/11/2015
Director/Board Member 58 11/11/2015
Chairman 50 11/11/2015
Date Insider Type Main position Quantity % Market Cap.
1/5/26 A Buy

Director

4,200 0.0010%
11/24/25 A Buy

Director

7,000 0.0017%
9/1/23 A Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-1.31%-13.17%-53.18%+31.64% 2.38B
+0.57%+0.13%+16.45%+78.10% 48.31B
-0.50%-0.41%+67.13%+107.90% 35.33B
-1.56%-3.13%-4.88%+32.80% 11.85B
-1.11%-3.73%+16.41%+81.64% 11.64B
-0.37%-0.19%+36.48%+136.73% 8.99B
-0.27%+0.42%+51.66%-6.22% 6.93B
-0.77%-3.00%+13.55%+32.01% 6.72B
+0.24%-4.02%+2.19%+192.78% 6.43B
+1.60%-9.55%-30.77%+8.47% 5.66B
Average -0.35%-1.87%+11.50%+69.59% 14.43B
Weighted average by Cap. -0.17%-0.96%+26.27%+81.03%

Financials

2026 *2027 *
Net sales 1.08B 160M 140M 130M 120M 224M 15.41B 229M 1.55B 606M 7.53B 599M 586M 26.15B 1.26B 186M 163M 152M 139M 261M 17.95B 267M 1.81B 706M 8.77B 698M 683M 30.46B
Net income 526M 77.73M 68.17M 63.35M 58.26M 109M 7.51B 112M 756M 295M 3.67B 292M 285M 12.74B -102M -15.07M -13.22M -12.29M -11.3M -21.19M -1.46B -21.63M -147M -57.22M -711M -56.56M -55.36M -2.47B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
23/07/26 CN¥35.53 -1.31% 9,608,287
22/07/26 CN¥36.00 -2.91% 13,663,622
21/07/26 CN¥37.08 +1.87% 16,486,924
20/07/26 CN¥36.40 -0.74% 13,121,235
17/07/26 CN¥36.67 -12.38% 21,128,034

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock